2026,将是创新药BD大年

医药魔方
Mar 02

2025年,MNC在创新药资产上的交易(包括并购和BD)创下历史新高。国信证券统计,2025年,创新药交易事件达到142起,其中并购/BD分别为36/106起,均创2015年至今新高。交易总金额则达到2,645亿美元,其中并购/BD总额分别为1,060/1,584亿美元,交易总额及BD总额均为2015年至今新高,并购总额仅次于2019及2023年。图片来源:国信证券目前来看,不论中外,MNC的“...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10